Glucocorticoid use and complications following immune checkpoint inhibitor use in melanoma
Kapil Agarwal, Nadia Yousaf and Daniel Morganstein
DOI: https://doi.org/10.7861/clinmed.2018-0440
Clin Med March 2020 Kapil Agarwal
AImperial College, London, UK
Roles: medical student
Nadia Yousaf
BRoyal Marsden Hospital, London, UK
Roles: consultant medical oncologist
Daniel Morganstein
CChelsea and Westminster Hospital, London, UK
Roles: consultant endocrinologist
Article Information
vol. 20 no. 2 163-168
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online March 18, 2020.
Copyright & Usage:
© Royal College of Physicians 2020. All rights reserved.
Author Information
- Kapil Agarwal, medical studentA,
- Nadia Yousaf, consultant medical oncologistB and
- Daniel Morganstein, consultant endocrinologistC⇑
- AImperial College, London, UK
- BRoyal Marsden Hospital, London, UK
- CChelsea and Westminster Hospital, London, UK
- Address for correspondence: Dr Daniel Morganstein, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK. Email: d.morganstein{at}ic.ac.uk
Article usage
Article Tools
Glucocorticoid use and complications following immune checkpoint inhibitor use in melanoma
Kapil Agarwal, Nadia Yousaf, Daniel Morganstein
Clinical Medicine Mar 2020, 20 (2) 163-168; DOI: 10.7861/clinmed.2018-0440
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.